|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Stock compensation expense | |||||
| Brazil foreign currency loss | |||||
| Pension termination expense | |||||
| Other | |||||
| Net changes in operating assets and liabilities: | |||||
| Affiliate payable | |||||
| Trade receivables | |||||
| Inventory | |||||
| Other assets | |||||
| Accounts payable | |||||
| Other liabilities | |||||
| Net cash provided by (used for) operating activities | |||||
| Investing activities | |||||
| Expenditures for property, plant and equipment | |||||
| Acquisition of business, net of cash acquired | |||||
| Issuance of secured loan | |||||
| Repayment of secured loan | |||||
| Purchase of U.S. Treasury bill | |||||
| Proceeds from maturity of U.S. Treasury bill | |||||
| Other | |||||
| Net cash provided by (used for) investing activities | |||||
| Financing activities | |||||
| Net additions (reductions) to revolving credit agreements | |||||
| Purchase of treasury stock | |||||
| Cash dividends paid | |||||
| Financing fees paid | |||||
| Other financing | |||||
| Net cash provided by (used for) financing activities | |||||
| Balance at the beginning of the year | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash | |||||
| Increase (decrease) for the year | |||||
| Balance at the beginning of the year | |||||
| Balance at the end of the year | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in prepaid expenses and other current assets | |||||
| Restricted cash included in other non-current assets | |||||
Loading...